2015
DOI: 10.1007/s00259-015-3143-1
|View full text |Cite
|
Sign up to set email alerts
|

Molecular imaging of cholinergic processes in prostate cancer using 11C-donepezil and 18F-FEOBV

Abstract: Uptake of PET tracers binding to cholinergic nerves was markedly higher in PC with a high GS than in PC with a low GS. This finding implies that (11)C-donepezil PET/CT may be able to differentiate between low-grade and high-grade PC.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…Advance Clinical Imaging Technologies Advanced imaging technologies such as positron-emission tomography (PET) using specific neuro-molecular targets can be very useful to identify patients who exhibit, for example, cholinergic activity in the tumor or at distant sites. The uptake of PET tracers binding to cholinergic nerves (i.e., (11)C-donepezil and (18)F-FEOBV) is considerably higher in prostate cancer tissues with a high severity (Gleason) score (Stokholm et al, 2016). Development of novel neuro-molecular tracers and performance of such specific neuro-tracer-PET imaging within clinical studies may help identify patients who may specifically benefit from neuro-modulatory therapies.…”
Section: Integrate Surgeonsmentioning
confidence: 99%
“…Advance Clinical Imaging Technologies Advanced imaging technologies such as positron-emission tomography (PET) using specific neuro-molecular targets can be very useful to identify patients who exhibit, for example, cholinergic activity in the tumor or at distant sites. The uptake of PET tracers binding to cholinergic nerves (i.e., (11)C-donepezil and (18)F-FEOBV) is considerably higher in prostate cancer tissues with a high severity (Gleason) score (Stokholm et al, 2016). Development of novel neuro-molecular tracers and performance of such specific neuro-tracer-PET imaging within clinical studies may help identify patients who may specifically benefit from neuro-modulatory therapies.…”
Section: Integrate Surgeonsmentioning
confidence: 99%